Kaikki kirjat 25 % alennuksella koodilla: BOOKS

  • check Yli 10 miljoonaa kirjaa
  • check Uutuuksia joka päivä
  • check Yli 1 miljoona asiakasta luottaa meihin
  • check Hyvät hinnat ja alennukset
  • check Toimitus koko Eurooppaan

RSM2 - Ginika Egesimba

englanti
2014-04-24
37,77 € 50,36 €

-25% koodilla BOOKS

Toimittajalla varastossa

Toimitus 12-18 arkipäivässä

30 päivän palautusoikeus

India and China have been identified by pharmaceutical companies as the future markets that would support drug research and development in a cost efficient manner This has become necessary as resources to conduct clinical studies dwindle coupled with the fact that pharmaceutical industries are under pressure to deliver quality medicine on time to the public Exploring and examining India and China s potentia ... Täydellinen kuvaus

Saatat myös pitää

Kuvaus

India and China have been identified by pharmaceutical companies as the future markets that would support drug research and development in a cost efficient manner This has become necessary as resources to conduct clinical studies dwindle coupled with the fact that pharmaceutical industries are under pressure to deliver quality medicine on time to the public Exploring and examining India and China s potential in a stepwise fashion provides the opportunity to dissect the good the bad and the ugly of globalization in a comparative approach This paper will cover areas like ethics in the conduct of studies good clinical practice GCP economic realities ICH influence intellectual property security and the role of government in global clinical trial

Lisätietoja

Kirjoittaja Ginika Egesimba
Julkaisija Anchor Academic Publishing
Julkaisuvuosi 2014
Kannen tyyppi Pehmeäkantinen
EAN 9783954892655
Kirjoita oma arvostelusi
Arvostelet: RSM2
Arvostelusi:

Goodreads-arvostelut

37,77 € 50,36 €